Impact of COVID-19 on the Management of Early-Stage Breast Cancer - Episode 6

Impact of COVID-19: Management of Early-Stage Breast Cancer

EP. 1: Case Overview: Early-Stage Breast Cancer During COVID-19
EP. 2: Management of Early-Stage Breast Cancer
EP. 3: Sequencing of Therapies for Early-Stage Breast Cancer
EP. 4: TAILORx Trial
EP. 5: Early-Stage Breast Cancer: Gene Expression Profiling
Now Viewing
EP. 6: Impact of COVID-19: Management of Early-Stage Breast Cancer

Anthony Lucci, MD, provides closing thoughts on the management of early-stage breast cancer moving forward given what we have learned from the COVID-19 pandemic.

Related Content:

Impact of COVID-19 on the Management of Early-Stage Breast CancerBreast Cancer
Patients With Postmenopausal HR+/HER2– Advanced Breast Cancer Experience Notable OS Benefit With Ribociclib/Letrozole Combo
[vic]-Trastuzumab Duocarmazine Improved Survival For HER2-Positive Metastatic Breast Cancer
Adjuvant/Neoadjuvant Chemotherapy Is Not Associated With Complications or Patient-Reported Outcomes Among Breast Cancer Survivors